Fridjtof Lund-Johannsen

Title: Fridjtof Lund-Johannsen: Innovator in Apoptosis Research

Introduction

Fridjtof Lund-Johannsen is a notable inventor based in Fremont, CA (US). He has made significant contributions to the field of apoptosis research, particularly through his innovative methods for identifying cells committed to apoptosis. His work has implications for understanding cell death and its associated processes.

Latest Patents

Fridjtof holds a patent for a method that identifies cells committed to apoptosis by determining changes in protein tyrosine phosphorylation. This novel approach combines methods used to study apoptosis and tyrosine phosphorylation at the single-cell level. His findings indicate that changes in cellular phosphotyrosine content strongly correlate with features of cell death, such as cell shrinkage, DNA fragmentation, and loss of membrane integrity. This patent represents a significant advancement in the study of hematopoietic cells and their apoptotic processes.

Career Highlights

Fridjtof Lund-Johannsen is currently associated with Becton Dickinson and Company Limited, where he continues to contribute to research and development in the field of cell biology. His expertise in apoptosis and cellular signaling has positioned him as a valuable asset in his organization.

Collaborations

Fridjtof has collaborated with various professionals in his field, including his coworker Peter Thompson. Their joint efforts have furthered the understanding of apoptosis and its implications in health and disease.

Conclusion

Fridjtof Lund-Johannsen's innovative work in apoptosis research highlights the importance of understanding cellular processes in health and disease. His contributions through patents and collaborations continue to influence the scientific community.